R. Bergenstal

Endocrinology, Diabetes and Metabolism · 2002–2019

A researcher in the Science corpus: 8 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom R. Bergenstal trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Michael Pollak (in Molecular Biology)

Papers from R. Bergenstal's perspective

Ordered by how strongly the researchers R. Bergenstal trusts endorse each paper. Same corpus, a different order for every researcher.

  1. 10-year follow-up of intensive glucose control in type 2 diabetes. (New England Journal of Medicine)
  2. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study (British medical journal)
  3. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. (The Lancet)
  4. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta‐analysis of controlled clinical trials (Journal of the American Medical Association (JAMA))
  5. Mapping and quantifying mammalian transcriptomes by RNA-Seq (Nature Methods)
  6. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials (Diabetes Care)
  7. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study (British medical journal)
  8. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation (Science)
  9. Insulin and insulin-like growth factor signalling in neoplasia (Nature Reviews. Cancer)
  10. Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality. (Archives of Internal Medicine)

Their papers